Trump’s AI Force and health-funding takeover raise alarms—what’s next for US power, markets, and security?

On September 20, 2026, multiple reports converged on a set of high-stakes moves by President Donald Trump that touch national security, industrial policy, and the governance of federal science funding. Politico reported that Trump is seeking to bring health-research funding under his direct control, and another report said he asked the budget chief to draft an order to formalize that shift. Separately, TASS reported that Trump announced the creation of an “AI Force” in a similar vein to the US “Space Force,” though he did not clarify whether it would be a new Armed Forces branch or a different kind of command structure. In parallel, a Secret Service incident described by O Globo involved a man who invaded a sidewalk near the White House with a car and demanded to speak with Trump, underscoring heightened security sensitivity around the president. Strategically, the health-funding push signals an attempt to centralize agenda-setting power over biomedical research, potentially reshaping priorities toward politically aligned programs, faster commercialization, or targeted national capabilities. That kind of control shift can rewire the relationship between the White House, federal agencies, universities, and private research sponsors, creating winners in favored therapeutic areas while risking delays or funding uncertainty for less-aligned projects. The “AI Force” announcement, even without details, points to a broader effort to institutionalize AI as a strategic security domain, potentially accelerating defense-related AI procurement, talent pipelines, and operational doctrine. Together, these moves suggest a governance model that favors executive direction over distributed bureaucratic decision-making, which could intensify institutional friction with regulators, oversight bodies, and parts of the research ecosystem. Market and economic implications are likely to concentrate in defense technology, AI infrastructure, and healthcare R&D funding channels. If an “AI Force” translates into new budgets or procurement pathways, it could support demand expectations for defense contractors, cloud and compute providers, and cybersecurity firms, with spillovers into semiconductors and data-center power equipment. The health-research funding order could affect biotech and healthcare services by changing the timing and certainty of grants, clinical trial support, and translational funding, potentially influencing risk premia for smaller firms reliant on federal programs. In the near term, investors may price higher volatility in policy-sensitive sectors—particularly those tied to federal R&D and defense AI—while also watching for any signals of regulatory pushback that could delay implementation. What to watch next is whether Trump’s health-funding order is formalized with specific mechanisms—such as which agency authority is transferred, what oversight remains, and how existing grants are treated. For the “AI Force,” the key trigger is clarification on structure: whether it becomes a new military service, a joint command, or a civilian-military hybrid, and what budget line items or hiring authorities are attached. Security-wise, the Secret Service incident raises the question of whether additional perimeter, vehicle-control, or threat-assessment measures will be announced following the event. Timeline-wise, the most immediate signals will come from the draft order’s language, any White House or OMB communications, and early procurement or staffing announcements tied to AI and defense technology over the next weeks.

Geopolitical Implications

• 01

  Centralizing biomedical research funding could reshape US strategic health priorities and influence global collaboration patterns.

• 02

  An “AI Force” could accelerate US defense AI operationalization, affecting deterrence and technology competition.

• 03

  Executive control over R&D funding may intensify institutional friction, with potential international spillovers.

Key Signals

• —Text and scope of the health-research funding order (authority transfer, oversight, treatment of existing grants).
• —Official clarification of “AI Force” structure and whether it is a new military branch or a command model.
• —Budget line items, hiring authorities, and early procurement tied to defense AI.
• —Post-incident security protocol changes around the White House.